Product Description
Alcaftadine eye drops are used to relieve itching of the eyes caused by pollen, ragweed, grass, animal hair, and dander. (Sourced from: https://www.mayoclinic.org/drugs-supplements/alcaftadine-ophthalmic-route/proper-use/drg-20074407?p=1)
Mechanisms of Action: H1 Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Ophthalmic
FDA Designation: *
Approval Status: Approved
Approved Countries: Argentina | Bangladesh | Brazil | Chile | Colombia | Dominican Republic | Ecuador | Egypt | India | Korea | Lebanon | Malaysia | Mexico | Philippines | Singapore | Thailand | Turkey | United Arab Emirates | United States | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|